APTOS 2022 is a hybrid meeting. Attendees can choose to join us online or on-site in Shenyang, China. Online registration is FREE while there is a registration fee of US$100 for those who opt to attend the meeting physically.
Click here for the APTOS 2022 Virtual Meeting Platform Handbook.
Lama A. Al-Aswad, MD, MPH is ophthalmologist with subspecialty in glaucoma and cataract with a strong interest in disease prevention and population health management. She is professor of ophthalmology at NYU Langone Health and the Vice Chair for Innovations and the Director of Teleophthalmology, Artificial Intelligence and Innovations and the Associate director of the glaucoma fellowship. She received her medical degree from Damascus University Medical School and completed her glaucoma research fellowship at the Mass Eye and Ear Infirmary, Harvard Medical School. Subsequently, she completed her residency in ophthalmology at the SUNY Downstate and her glaucoma fellowship at the University of Tennessee.
In 2015, Dr. Al-Aswad conferred the degree of Masters of Public Health from Columbia University, Mailman School of Public Health for her work in healthcare policy and management. Dr. Al-Aswad, is the past president of the NY Glaucoma Society and the Women in Ophthalmology. She also holds an appointment with the FDA as a voting member on the ophthalmic device panel.
Dr. Al-Aswad is a believer in prevention of blindness as evident from her large-scale glaucoma screening project in NYC where she screened more than 8500 individuals for glaucoma. In 2017, she launched the tele-ophthalmology screening project for the four-leading cause of blindness using a mobile tele-ophthalmology unit equipped with state of the art devices and staffed with technicians, linked in real-time to a reading center. In 2019, she piloted the first teleophthalmology Kiosk for screening for the four leading causes of blindness. Dr. Al-Aswad has experience in building data capturing systems in addition to app development. She is currently working on validating artificial intelligence systems in glaucoma and diabetic retinopathy screening as a tool in blindness prevention.
Dr Richa Tiwari is a Program Manager at Google Health, leading research and deployment of AI technologies in the APAC region. She is passionate about increasing access to care and bringing advances in healthcare through digital innovations. Before Google, Richa has over a decade of experience in Pharma medical affairs and in cancer research. She holds a PhD in Molecular Genetics & Biology from The University of Texas at Austin and a B.S. with honors in Biology from Brandeis University.
Friedrich Chen was born in Shanghai. He joined Orbis International in 2018. He now works as Cybersight Manager of China in Orbis International, and he is in charge of the implementation and localization of telemedicine, online learning and mentorship services for eye health professionals across China on Cybersight, as well as the integration of Cybersight and other new telemedicine technologies with on-site projects that connect eye health professionals with new tools and capabilities to deliver better care to their patients in China. Before he joined Orbis, he was a Research Associate in GLG, responsible for providing industrial consultation, data collection and analysis.
Chen graduated as Cand. Mag. with majored in Philosophy from University of Copenhagen in 2017, and he got his bachelor’s degree in Tongji University with same major in 2014.
Dr Hanruo Liu is Associate Professor in Ophthalmology at Beijing Tongren Eye Center, Capital Medical University. She currently serves as the Deputy Head of the Ophthalmology AI Group of the China Medical Equipment Association. She was awarded the Beijing Nova Program of Science and Technology and the Beijing Young Scientist Award, both of which recognize scientists under 35 across all domains in science, technology and education. For her AI work, she won the 1st Prize in the Beijing Science and Technology for Innovation Award in 2019. She was also a key member on the Beijing Strategic Technology Talent Team and a finalist in the Beijing Hospitals Authority Youth Program. She has obtained ten invention patents in the field of AI screening for diabetic retinopathy, age-related macular degeneration and glaucoma.
